KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge, Carolyn C. Compton · Annals of Surgical Oncology · 2010 · 9.2K citations · Full text

Medicine, Oncology, Surgery +14

Genomic Evolution of Breast Cancer Metastasis and Relapse

Lucy Yates, Stian Knappskog, David C. Wedge et al. · Cancer Cell · 2017 · 693 citations · Full text

Medicine, Genetics, Oncology +17

Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance

Aliki Stathopoulou, Ioannis G. Vlachonikolis, D. Mavroudis et al. · Journal of Clinical Oncology · 2002 · 340 citations

Medicine, Molecular Medicine, Oncology +13

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

Yingbo Shao, Xianfu Sun, Yaning He et al. · PLoS ONE · 2015 · 232 citations · Full text

Medicine, Oncology, Pathology +17

Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection

Xin‐Rong Yang, Yang Xu, Guo‐Ming Shi et al. · Clinical Cancer Research · 2008 · 150 citations

Medicine, Oncology, Pathology +17